GARACI, ENRICO
 Distribuzione geografica
Continente #
NA - Nord America 57.348
AS - Asia 7.769
EU - Europa 6.627
SA - Sud America 957
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 16
Totale 72.824
Nazione #
US - Stati Uniti d'America 57.135
SG - Singapore 3.739
CN - Cina 1.948
UA - Ucraina 972
DE - Germania 916
IT - Italia 912
BR - Brasile 806
RU - Federazione Russa 747
FR - Francia 670
HK - Hong Kong 623
PL - Polonia 568
IE - Irlanda 541
VN - Vietnam 515
SE - Svezia 419
GB - Regno Unito 342
FI - Finlandia 279
KR - Corea 248
JP - Giappone 192
CA - Canada 125
BD - Bangladesh 115
IN - India 102
NL - Olanda 57
AR - Argentina 52
ES - Italia 52
MX - Messico 46
BE - Belgio 43
TR - Turchia 39
ID - Indonesia 38
IQ - Iraq 30
UZ - Uzbekistan 28
CL - Cile 23
EU - Europa 23
ZA - Sudafrica 23
IL - Israele 22
EC - Ecuador 21
PK - Pakistan 20
AT - Austria 18
CO - Colombia 17
IR - Iran 16
CZ - Repubblica Ceca 15
AU - Australia 14
AL - Albania 12
EG - Egitto 12
SA - Arabia Saudita 12
VE - Venezuela 12
AZ - Azerbaigian 11
PH - Filippine 11
PY - Paraguay 11
CH - Svizzera 9
MA - Marocco 9
DK - Danimarca 8
DZ - Algeria 8
JM - Giamaica 7
JO - Giordania 7
PE - Perù 7
TN - Tunisia 7
KE - Kenya 6
KG - Kirghizistan 6
LT - Lituania 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
HN - Honduras 5
NP - Nepal 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
BB - Barbados 4
CR - Costa Rica 4
GR - Grecia 4
MD - Moldavia 4
NI - Nicaragua 4
PS - Palestinian Territory 4
PT - Portogallo 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DM - Dominica 3
KZ - Kazakistan 3
LB - Libano 3
MT - Malta 3
MY - Malesia 3
OM - Oman 3
TW - Taiwan 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BS - Bahamas 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
HR - Croazia 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
RO - Romania 2
SC - Seychelles 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
BF - Burkina Faso 1
Totale 72.796
Città #
Woodbridge 16.755
Wilmington 14.013
Houston 13.041
Ann Arbor 1.823
Singapore 1.557
Fairfield 1.233
Ashburn 1.005
Chandler 947
Jacksonville 895
San Jose 722
Hong Kong 620
Beijing 582
Dublin 536
Kraków 522
Seattle 495
Zhengzhou 483
Cambridge 423
Medford 416
Dearborn 337
Rome 262
Santa Clara 262
The Dalles 244
Dallas 207
Los Angeles 195
Lawrence 191
Council Bluffs 190
New York 190
Tokyo 162
Ho Chi Minh City 153
Mülheim 152
Hanoi 134
Buffalo 129
Shanghai 121
Moscow 107
Menlo Park 86
Boardman 85
Milan 85
Hangzhou 84
San Diego 83
Helsinki 66
Lauterbourg 61
San Mateo 60
Falls Church 56
São Paulo 56
Frankfurt am Main 54
Munich 51
Chicago 49
Toronto 48
Porto Alegre 43
University Park 41
Brussels 40
London 39
Mountain View 39
Orem 39
Guangzhou 38
Montreal 38
Columbus 35
Hefei 33
Nanjing 33
Redwood City 33
Warsaw 33
Verona 31
Norwalk 27
Denver 26
Kunming 26
Rio de Janeiro 26
Brooklyn 25
Palo Alto 25
Belo Horizonte 23
Haiphong 23
North Bergen 22
Turku 22
Atlanta 21
Chennai 21
Da Nang 21
Phoenix 19
Yongsan-gu 19
Amsterdam 18
Jakarta 18
Stockholm 18
Detroit 17
Saint Petersburg 17
Curitiba 15
Auburn Hills 14
Naples 14
Nuremberg 14
Nürnberg 14
San Francisco 14
Washington 14
Baghdad 13
Brno 13
Nanchang 13
Redondo Beach 13
Brasília 12
Florence 12
Jinan 12
Poplar 12
Portici 12
Salt Lake City 12
Ankara 11
Totale 61.211
Nome #
Thymosin α1 inserts N terminus into model membranes assuming a helical conformation 646
Thymosin alpha 1: from bench to bedside 629
Combination treatment with zidovudine, thymosin alpha 1 and interferon-alpha in human immunodeficiency virus infection. 586
Influence of cocaine on murine immune surveillance. 581
Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies 577
Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice 573
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 562
Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance 555
Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice 542
Historical review on thymosin α1 in oncology: preclinical and clinical experiences 542
A randomized controlled study for the evaluation of the activity of a triple combination of zidovudine, thymosin-alpha(1) and interferon-alpha in HIV-infected individuals with CD4 counts between 200 and 500 cells/mm(3) 540
Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer 539
Vaccination with a synthetic nonapeptide expressed in human tumors prevents colorectal cancer liver metastases in syngeneic rats 535
Effect of combined alpha IFN and prostaglandin A(1) treatment on vesicular stomatitis virus replication and heat shock protein synthesis in epithelial cells 507
Influenza A virus replication is dependent on an antioxidant pathway that involves GSH and Bcl-2 507
Thymosin α1 Interacts with Exposed Phosphatidylserine in Membrane Models and in Cells and Uses Serum Albumin as a Carrier 507
ANTITUMOR EFFECT OF COMBINED TREATMENT WITH THYMOSIN ALPHA-1 AND INTERLEUKIN-2 AFTER 5-FLUOROURACIL IN LIVER METASTASES FROM COLORECTAL-CANCER IN RATS 505
Antitumour effect of OM-174 and cyclophosphamide on murine B16 melanoma in different experimental conditions 504
Effects of cocaine administration to influenza virus-immunized mice on cytokine profiles of individual splenic CD4(+) and CD8(+) T cells 504
Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1 502
Imbalance in corneal redox state during herpes simplex virus 1-induced keratitis in rabbits. Effectiveness of exogenous glutathione supply 500
Analisi dell’espressione di retrovirus endogeni umani (HERV) in linfomonociti di soggetti sani di varie eta’: indicazioni per un possibile ruolo nello sviluppo 498
Antiviral activity of cyclopentenone prostaglandins: Block of virus protein synthesis and induction of stress proteins in polarized monkey kidney cells 497
Thymosin α1 inserts N terminus into model membranes assuming a helical conformation 497
Thymosin alpha 1 and HIV-1: Recent advances and future perspectives 497
Fluconazole resistance in Candida albicans: a review of mechanisms. 495
Human endogenous retroviruses and ADHD 490
activation of human endogenous retrovirus k and cellular modifications in human melanoma cell line: gene expression analysis 488
Inhibition of NF-κB activation sensitizes U937 cells to 3'-azido-3'-deoxythymidine induced apoptosis. 487
Differential effects of acute morphine administrations on polymorphonuclear cell metabolism in various mouse strains 486
Combination low-dose lymphoblastoid interferon and thymosin alpha(1) therapy in the treatment of chronic hepatitis B 485
Fluconazole resistance in Candida albicans: A review of mechanisms 485
Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV 484
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro 484
Activation of human endogenous retrovirus k (herv-k) and cellular modifications in a human melanoma cell line: trascriptional profiling analysis 483
Intracellular GSH content and HIV replication in human macrophages 482
Inhibition of influenza A virus replication by resveratrol 481
Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma 479
Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: Efficiency, metabolism and activity against human immunodeficiency virus or herpes simplex virus 477
Effect of acute or daily cocaine administration on cellular immune response and virus infection in mice 476
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 476
Ruolo eziopatogenetico dei retrovirus endogeni umani: il caso del melanoma 472
TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death. 469
Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV 468
Macrophages and HIV infection: Therapeutical approaches toward this strategic virus reservoir 468
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis 467
Herpesviruses and periodontal disease: a cautionary tale 467
Glutathione inhibits HIV replication by acting at late stages of the virus life cycle 466
Adhd and human endogenous retroviruses 466
Combined treatment with thymosin-alpha 1 and low dose interferon-alpha after dacarbazine in advanced melanoma 464
INHIBITION OF RAT FIBROBLAST CELL-PROLIFERATION AT SPECIFIC CELL-CYCLE STAGES BY COCAINE 462
Effects of in vivo PGE2 administration on IL 2 production by splenocytes collected from normal and tumor-bearing mice . vol. 2, p. 31-40 462
PCT (WO/2006/069812) RETROTRANSPOSON INHIBITION IN THERAPY 461
Activation of human endogenous retrovirus K (HERV-K) and cellular modifications in human melanoma cell line: transcriptional profiling analysis 460
Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice 458
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression 457
Cocaine potentiates the switch between latency and replication of Epstein-Barr virus in Raji cells. 456
ACTIVATION OF HUMAN ENDOGENOUS RETROVIRUS K AND CELLULAR MODIFICATIONS IN HUMAN MELANOMA CELL LINE: GENE EXPRESSION ANALYSIS. 456
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 453
Anti-tumour immunogens and vaccines 452
In vivo recovery of natural killer cell activity by the association of thymosin α1 and cytokines during cocaine administration 449
Effect of thymosin alpha 1 on cocaine-induced inhibition of T cell dependent murine immune response. 449
Combination therapy with BRMs in cancer and infectious diseases 447
Analisi filogenetica di un isolato di herv-k ottenuto da una lesione di melanoma metastatico umano. 447
Depressed T-cell proliferation and polymorphonuclear superoxide anion production in mice treated with cocaine 445
Combination low-dose lymphoblastoid interferon and thymosin α1 therapy in the treatment of chronic hepatitis B 443
Induction of apoptosis in thymocytes by prostaglandin E2 in vivo 443
Treatment of aspergillus infection with thymosin alpha 1 443
Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling 442
Inhibition of endogenous reverse transcriptase antagonizes human tumor growth 442
Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application 439
New studies about the insertion mechanism of Thymosin α1 in negative regions of model membranes as starting point of the bioactivity 439
Thymosin α1 and cancer: action on immune effector and tumor target cells 438
Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis 437
Cocaine effects on cell-cycle progression. 435
Studies on the induction of human lymphocyte apoptosis by prostaglandin-E2 433
Modulatory role of PGE2 on IL-2 production after in vivo treatment. 432
Inibitori Delle Istone Deacetilasi Riattivano Il Retrovirus Endogeno Umano-K In Cellule Di Melanoma Umano 431
Thymosin-alpha 1 regulates MHC class I expression in FRTL-5 cells at transcriptional level 430
The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation 430
Effect of di-M-PGE2 on T cell differentiation. Flow cytometry study at thymus level 430
INFLUENZA DEL MICROAMBIENTE SULLA PLASTICITA’ DI CELLULE DI MELANOMA ESPRIMENTI HERV-K. 430
Azione antivirale delle prostaglandine: blocco della sintesi delle proteine virali ed induzione di proteine da stress in cellule di mammifero. 427
Interferon-lambda in immunocompetent individuals with a history of recurrent herpes labialis 424
Correlation between the effects of prostaglandins and interferon on B-16 melanoma growth and their modulation on natural killer activity 424
Cidofovir on HHV-8 in BCBL-1 cells 423
Thymosin αlpha1 potentiatesthe release of antiviral factors by cd8+ cells: new tools for antiviral therapy 422
Effect of PGE2 on c-Myc and Bcl-2 production and programmed cell death in human lymphocytes. 421
Studio sulla relazione esistente tra Nerve growth factor (NGF), infezione da Herpesvirus umano 8 (HHV-8 o KSHV) e patologie HHV-8-correlate. 421
Combination thymosin alpha(1) and lymphoblastoid interferon treatment in chronic hepatitis C 420
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a 418
Modifications in spleen lymphocyte subsets after cyclophosphamide and 16,16-dimethyl prostaglandin E2 administration in mice 417
Loss of GSH, oxidative stress, and decrease of intracellular pH as sequential steps in viral infection 416
Thymosin alpha1 activates the TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo 415
MiR-34a regulates cell proliferation, morphology and function of newborn neurons resulting in improved behavioural outcomes 412
Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study 411
HERVs expression in autism spectrum disorders 411
comparative cellular signal patway analysis of metastatic colorectal cancer in human and preclinical animal model 410
Downregulation of thymosin beta4 in neural progenitor grafts promotes spinal cord regeneration 410
Human Endogenous Retroviruses-K (HERV-K) expression correlates with stemness features in melanoma cells. 410
Totale 47.120
Categoria #
all - tutte 158.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 0 0 119
2021/20221.893 49 200 126 101 57 200 76 79 147 172 84 602
2022/20232.651 242 166 79 384 258 600 185 156 212 13 271 85
2023/2024837 105 30 65 33 83 147 103 59 16 17 18 161
2024/20255.550 169 961 573 303 155 338 344 274 458 359 897 719
2025/20267.279 589 335 861 581 568 216 735 979 889 890 365 271
Totale 73.178